These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 12412816)

  • 1. Evidence from the aged orchidectomized male rat model that 17beta-estradiol is a more effective bone-sparing and anabolic agent than 5alpha-dihydrotestosterone.
    Vandenput L; Boonen S; Van Herck E; Swinnen JV; Bouillon R; Vanderschueren D
    J Bone Miner Res; 2002 Nov; 17(11):2080-6. PubMed ID: 12412816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of estradiol-17beta, testosterone and a black cohosh preparation on bone and prostate in orchidectomized rats.
    Seidlová-Wuttke D; Jarry H; Pitzel L; Wuttke W
    Maturitas; 2005 Jun; 51(2):177-86. PubMed ID: 15917159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive protective effects of estrogen and androgen treatment on trabecular bone in ovariectomized rats.
    Tivesten A; Movérare-Skrtic S; Chagin A; Venken K; Salmon P; Vanderschueren D; Sävendahl L; Holmäng A; Ohlsson C
    J Bone Miner Res; 2004 Nov; 19(11):1833-9. PubMed ID: 15476584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dried plum prevents bone loss in a male osteoporosis model via IGF-I and the RANK pathway.
    Franklin M; Bu SY; Lerner MR; Lancaster EA; Bellmer D; Marlow D; Lightfoot SA; Arjmandi BH; Brackett DJ; Lucas EA; Smith BJ
    Bone; 2006 Dec; 39(6):1331-42. PubMed ID: 16890505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen deficiency induces high turnover osteopenia in aged male rats: a sequential histomorphometric study.
    Erben RG; Eberle J; Stahr K; Goldberg M
    J Bone Miner Res; 2000 Jun; 15(6):1085-98. PubMed ID: 10841177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model.
    Venken K; De Gendt K; Boonen S; Ophoff J; Bouillon R; Swinnen JV; Verhoeven G; Vanderschueren D
    J Bone Miner Res; 2006 Apr; 21(4):576-85. PubMed ID: 16598378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Puerariae radix prevents bone loss in castrated male mice.
    Wang X; Wu J; Chiba H; Yamada K; Ishimi Y
    Metabolism; 2005 Nov; 54(11):1536-41. PubMed ID: 16253645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E2 administration prevents bone loss induced by orchidectomy in rats.
    Li M; Jee WS; Ke HZ; Tang LY; Ma YF; Liang XG; Setterberg RB
    J Bone Miner Res; 1995 Jan; 10(1):66-73. PubMed ID: 7747632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen replacement therapy improves function in male rat muscles independently of hypertrophy and activation of the Akt/mTOR pathway.
    Hourdé C; Jagerschmidt C; Clément-Lacroix P; Vignaud A; Ammann P; Butler-Browne GS; Ferry A
    Acta Physiol (Oxf); 2009 Apr; 195(4):471-82. PubMed ID: 18801052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency.
    Vanderschueren D; Van Herck E; Suiker AM; Visser WJ; Schot LP; Bouillon R
    Endocrinology; 1992 May; 130(5):2906-16. PubMed ID: 1572302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An aged rat model of partial androgen deficiency: prevention of both loss of bone and lean body mass by low-dose androgen replacement.
    Vanderschueren D; Vandenput L; Boonen S; Van Herck E; Swinnen JV; Bouillon R
    Endocrinology; 2000 May; 141(5):1642-7. PubMed ID: 10803572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orchiectomy upregulates free soluble RANKL in bone marrow of aged rats.
    Proell V; Xu H; Schüler C; Weber K; Hofbauer LC; Erben RG
    Bone; 2009 Oct; 45(4):677-81. PubMed ID: 19501680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of 5alpha-reductase blocks prostate effects of testosterone without blocking anabolic effects.
    Borst SE; Lee JH; Conover CF
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E222-7. PubMed ID: 15367394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the androgen receptor in skeletal homeostasis: the androgen-resistant testicular feminized male mouse model.
    Vandenput L; Swinnen JV; Boonen S; Van Herck E; Erben RG; Bouillon R; Vanderschueren D
    J Bone Miner Res; 2004 Sep; 19(9):1462-70. PubMed ID: 15312246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT; Le H; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tibolone exerts its protective effect on trabecular bone loss through the estrogen receptor.
    Ederveen AG; Kloosterboer HJ
    J Bone Miner Res; 2001 Sep; 16(9):1651-7. PubMed ID: 11547834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
    Verhaeghe J; van Bree R; Van Herck E; Thomas H; Skottner A; Dequeker J; Mosekilde L; Einhorn TA; Bouillon R
    J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The estrogen receptor ligand ICI 182,780 does not impair the bone-sparing effects of testosterone in the young orchidectomized rat model.
    Vandenput L; Swinnen JV; Van Herck E; Verstuyf A; Boonen S; Bouillon R; Vanderschueren D
    Calcif Tissue Int; 2002 Mar; 70(3):170-5. PubMed ID: 11907714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tibolone, a steroid with a tissue-specific hormonal profile, completely prevents ovariectomy-induced bone loss in sexually mature rats.
    Ederveen AG; Kloosterboer HJ
    J Bone Miner Res; 1999 Nov; 14(11):1963-70. PubMed ID: 10571697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lasofoxifene (CP-336,156), a selective estrogen receptor modulator, prevents bone loss induced by aging and orchidectomy in the adult rat.
    Ke HZ; Qi H; Crawford DT; Chidsey-Frink KL; Simmons HA; Thompson DD
    Endocrinology; 2000 Apr; 141(4):1338-44. PubMed ID: 10746637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.